Cancer Fighters Constituents
Corvus Pharmaceuticals
9.42 0.69 7.90 Stock | CRVS |
TG Therapeutics
35.00 0.74 2.16 Stock | TGTX |
Zai Lab
28.13 0.58 2.11 Stock | ZLAB |
argenx NV ADR
614.59 7.43 1.22 Stock | ARGX |
PTC Therapeutics
45.11 -0.9 -1.96 Stock | PTCT |
Puma Biotechnology
3.23 0.09 2.87 Stock | PBYI |
AN2 Therapeutics
1.37 -0.02 -1.44 Stock | ANTX |
XBiotech
7.35 0.54 7.93 Stock | XBIT |
BeiGene
206.16 14.05 7.31 Stock | BGNE |
HUTCHMED DRC
18.43 1.05 6.04 Stock | HCM |
MacroGenics
3.64 0.24 7.06 Stock | MGNX |
Novocure
19.69 1.81 10.12 Stock | NVCR |
Blueprint Medicines Corp
95.10 0.47 0.50 Stock | BPMC |
AngioDynamics
7.02 0.03 0.43 Stock | ANGO |
BeyondSpring
1.89 0.04 2.16 Stock | BYSI |
Cellectis SA
2.13 -0.01 -0.47 Stock | CLLS |
CytomX Therapeutics
1.02 0.06 6.25 Stock | CTMX |
Iovance Biotherapeutics
9.40 0.28 3.07 Stock | IOVA |
Geron
4.17 0.11 2.71 Stock | GERN |
Curis Inc
4.45 0.42 10.42 Stock | CRIS |
This list of potential positions covers biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases in USA. To view opportunities from different investing ideas or change the current investment horizon please use the panel above to switch your theme or use buttons below to analyze or optimize Cancer Fighters, or select one of many other different investing ideas from the investing ideas screen.
A typical investing theme composed of about 20 constituents, similar to a mutual fund or an ETF:
these twenty equities are selected programmatically and evaluated daily using several Macroaxis
equity rating mechanisms. The investor then can optimize these screened instruments to
generate an optimal portfolio for a given investing idea or a nitch such as Cancer Fighters.